Publication | Closed Access
Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis
318
Citations
33
References
2012
Year
InflammationIntestinal PermeabilityNon-selective Betablocker TherapyAutoimmune DiseaseHepatologyMedicineLiver PhysiologyImmunologyGastroenterologyHepatology InflammationLiver DiseaseUlcerative ColitisPharmacologySerum Levels
| Year | Citations | |
|---|---|---|
Page 1
Page 1